Fig. 1. Schematic Representation of the Experiment
Fig. 2. Effects of Gwakhyangjeonggi-san(GJS) on Clinical Aspect in AD Induced Mice Sham, Normal mice with oil treatment; AD, DNCB-induced atopic dermatitis model; GJS, Orally GJS treated DNCB-induced atopic dermatitis model.
Fig. 3. Change of Atopic Dermatitis Index after Gwakhyangjeonggi-san(GJS) Treatment
Fig. 4. Histologic Features of Skin Lesion and Epithelial Thickness
Fig. 5. Change of IgE Levels after Gwakhyangjeonggi-san(GJS) Treatment
Fig. 6. Change of TSLP expression after Gwakhyangjeonggi-san(GJS) treatment
Fig. 7. Change of Mast Cell Infiltration after Gwakhyangjeonggi-san(GJS) Treatment.
Fig. 8. Change of Expression of IL-4 and TNF-α after Gwakhyangjeonggi-san(GJS) Treatment
Fig. 9. Change of Expression of (A) IL-4, (B) TNF-α and (C) IL-6 after Gwakhyangjeonggi-san(GJS) Treatment
Table 1. Prescription of Gwakhyangjeonggi-san
참고문헌
- Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. Journal of the American Academy of Dermatology. 2014;70(2):338-51. https://doi.org/10.1016/j.jaad.2013.10.010
- Ministry of Health and Welfare. Korea youth risk behavior survey [Internet]. Korean Statistical information service. 2018. Available from: URL: http://kosis.kr/statHtml/statHtml.do?orgId=117&tblId=DT_117_12_Y094&conn_path=I2.
- Ministry of Health and Welfare. Korea National Health and Nutrition Examination Survey [Internet]. 2019. Available from: URL: http://kosis.kr/statHtml/statHtml.do?orgId=117&tblId=DT_11702_N114&conn_path=I2.
- Krakowski AC, Eichenfield LF, Dohil MA. Management of atopic dermatitis in the pediatric population. Pediatrics. 2008;122(4):812-24. https://doi.org/10.1542/peds.2007-2232
- Jones MP, Walker MM, Ford AC, Talley NJ. The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Alimentary Pharmacology and Therapeutics. 2014;40(4):382-91. https://doi.org/10.1111/apt.12846
- Walker MM, Powell N, Talley NJ. Atopy and the gastrointestinal tract - a review of a common association in unexplained gastrointestinal disease. Expert Review of Gastroenterology and Hepatology. 2014;8(3):289-99. https://doi.org/10.1586/17474124.2014.881716
- Korea Institute of Oriental Medicine. Atopic dermatitis Korean Medicine Clinical Practice Guideline. Seoul: Elsevier Korea. 2015:30.
- Yuan Z, Cao Z, Guo Q, Yang Z. The Clinical Efficacy Observation of Huoxiang Zhengqi Caplsule to Functional Dyspepsia. Liaoning zhong yi zazhi. 2011; 38(3):494-6.
- Ko SJ, Han G, Kim SK, Seo JG, Chung WS, Ryu B, et al. Effect of Korean Herbal Medicine Combined with a Probiotic Mixture on Diarrhea-Dominant Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Trial. Evidence-based Complementary and Alternative Medicine. 2013;2013:1-10.
- Lee SY, Bae HS, Park SS. A Case Report of Soeumin Atopic Dermatitis Patient Improved by Gwakhyangjeonggi-san. Journal of Sasang Constitutional Medicine. 2010;22(4):106-12.
- Yang SW, Kim YB, Kim SY, Choi H, Sohn YJ, Park SK, et al. Effect of several herbal medicines on atopic dermatitis patients' SCORAD and cytokin levels. The Korean Journal of Oriental Medical Prescription. 2008;16(1):185-205.
- Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. Journal of Basic and Clinical Pharmacy. 2016;7(2):27-31. https://doi.org/10.4103/0976-0105.177703
- Rha YH, Choi SH. Risk factors associated with development of atopic dermatitis. Allergy Asthma & Respiratory Diseases. 2009;19(2):91-4.
- Palmer CN, Irvine AD, Terron- Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nature Genetics. 2006;38(4):441-6. https://doi.org/10.1038/ng1767
- Strachan DP. Hay fever, hygiene, and household size. British Medical Journal. 1989;299(6710):1259-60. https://doi.org/10.1136/bmj.299.6710.1259
- Nutten S. Atopic Dermatitis: Global Epidemiology and Risk Factors. Annals of Nutrition and Metabolism. 2015;66(suppl 1):8-16. https://doi.org/10.1159/000370220
- Gu S, Yang AW, Xue CC, Li CG, Pang C, Zhang W, et al. Chinese herbal medicine for atopic eczema. Cochrane Database of Systematic Reviews. 2013;(9):1-132.
- Kobayashi H, Ishii M, Takeuchi S, Tanaka Y, Shintani T, Yamatodani A, et al. Efficacy and Safety of a Traditional Herbal Medicine, Hochu-ekki-to in the Long-term Management of Kikyo(Delicate Constitution) Patients with Atopic Dermatitis: A 6-month, Multicenter, Double-blind, Randomized, Placebo-controlled Study. Evidence-based Complementary and Alternative Medicine. 2010;7(3):367-73. https://doi.org/10.1093/ecam/nen003
- Cheng HM, Chiang LC, Jan YM, Chen GW, Li TC. The efficacy and safety of a Chinese herbal product(Xiao-Feng-San) for the treatment of refractory atopic dermatitis: a randomized, double-blind, placebo-controlled trial. International Archives of Allergy and Immunology. 2011;155(2):141-8. https://doi.org/10.1159/000318861
- Korea Institute of Oriental Medicine. Mediclassics [Internet]. Korea Institute of Oriental Medicine. 2015. [cited 19 Apr 2019]. Available from: URL: https://mediclassics.kr/books/8/volume/10#content_1156
- Jeong SJ, Kim OS, Yoo SR, Seo CS, Kim Y, Shin HK. Anti-inflammatory and antioxidant activity of the traditional herbal formula Gwakhyangjeonggisan via enhancement of heme oxygenase1 expression in RAW264.7 macrophages. Molecular Medicine Reports. 2016;13(5):4365-71. https://doi.org/10.3892/mmr.2016.5084
- Han Y. Experimental study on Huoxiangzhengqi decoction and it's drug-serum against allergic reaction. Kunming: Kunming medical university; 2006.
- Martel BC, Lovato P, Baumer W, Olivry T. Translational Animal Models of Atopic Dermatitis for Preclinical Studies. Yale Journal of Biology and Medicine. 2017;90(3):389-402.
- Yamaguchi T, Maekawa T, Nishikawa Y, Nojima H, Kaneko M, Kawakita T, et al. Characterization of itch-associated responses of NC mice with mite-induced chronic dermatitis. Journal of Dermatological Science. 2001;25(1):20-8. https://doi.org/10.1016/S0923-1811(00)00099-2
- Indra AK. Epidermal TSLP: a trigger factor for pathogenesis of atopic dermatitis. Expert Review of Proteomics. 2013;10(4):309-11. https://doi.org/10.1586/14789450.2013.814881
- Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nature Immunology. 2002;3(7):673-80. https://doi.org/10.1038/ni805
- Cianferoni A, Spergel J. The importance of TSLP in allergic disease and its role as a potential therapeutic target. Expert Review of Clinical Immunology. 2014;10(11):1463-74. https://doi.org/10.1586/1744666X.2014.967684
- Serezani APM, Bozdogan G, Sehra S, Walsh D, Krishnamurthy P, Sierra Potchanant EA, et al. IL-4 impairs wound healing potential in the skin by repressing fibronectin expression. The Journal of Allergy and Clinical Immunology. 2017;139(1):142-51.e5. https://doi.org/10.1016/j.jaci.2016.07.012
- Leung DYM. Role of IgE in atopic dermatitis. Current Opinion in Immunology. 1993;5(6):956-62. https://doi.org/10.1016/0952-7915(93)90112-6
-
Danso MO, van Drongelen V, Mulder A, van Esch J, Scott H, van Smeden J, et al.
$TNF-{\alpha}$ and Th2 Cytokines Induce Atopic Dermatitis-Like Features on Epidermal Differentiation Proteins and Stratum Corneum Lipids in Human Skin Equivalents. Current Opinion in Immunology. 2014;134(7):1941-50. - Sumimoto S, Kawai M, Kasajima Y, Hamamoto T. Increased plasma tumour necrosis factor-alpha concentration in atopic dermatitis. Archives of Disease in Childhood. 1992;67(3):277-9. https://doi.org/10.1136/adc.67.3.277
- Toshitani A, Ansel JC, Chan SC, Li SH, Hanifin JM. Increased Interleukin 6 Production by T Cells Derived from Patients with Atopic Dermatitis. Journal of Investigative Dermatology. 1993;100(3):299-304. https://doi.org/10.1111/1523-1747.ep12469875